Aaron Suri

Aaron Suri is an experienced investor currently working at Nucleus Capital, where responsibilities include supporting early-stage, purpose-driven entrepreneurs in synthetic biology and climate technology since September 2021. Prior experience includes internships at OKRA Technologies, focusing on AI analytics for pharmaceuticals, and Cambridge Enterprise, where contributions were made to invest in academic-led startups. Additional internships at IQ Capital Partners LLP and Amadeus Capital Partners enhanced expertise in deep-tech VC and global technology investments, respectively. Education was completed at the University of Nottingham.